PROTEIN PATHWAYS

Protein Pathways, Inc. ("the Company") is an emerging leader in utilizing computational methods to direct and optimize pathway-based therapeutic drug development. Our proprietary computational technology, ProNexus, has enabled us to establish a strategic position in the industry-wide effort to construct a complete human protein interaction map. This human protein interaction map will facilitate the compilation of complete intracellular pathways and the identification of new drug targets. We intend to validate these drug targets experimentally, and this capability will be a key step in the transition of the Company to a stand-alone drug discovery provider... By integrating drug databases with our ProNexus technology we have developed the Rational Environment for Drug Design (REDD) platform. REDD gives us critically important information on potential drug efficacy and toxicity, before the costly stage of preclinical trials. REDD permits a revolutionary advance in prioritizing new drugs..

Also known as: Protein Pathways, Inc.